A multicenter phase II study of TSU-68, a novel oral multiple tyrosine kinase inhibitor, in patients with metastatic breast cancer progressing despite prior treatment with an anthracycline-containing regimen and taxane

✍ Scribed by Suzuki, Yasuhiro; Saeki, Toshiaki; Aogi, Kenjiro; Toi, Masakazu; Fujii, Hirofumi; Inoue, Kenichi; Watanabe, Toru; Fujiwara, Yasuhiro; Ito, Yoshinori; Takatsuka, Yuichi; Iwata, Hiroji; Arioka, Hitoshi; Tokuda, Yutaka

• Book ID: 121629405
• Publisher: Springer
• Year: 2012
• Tongue: English
• Weight: 259 KB
• Volume: 18
• Category: Article
• ISSN: 1341-9625
• DOI: 10.1007/s10147-012-0421-9